Hence, although SHH/GLI signaling has been well characterized to play a pivotal role in driving BCC initiation, there is also evidence that further support our findings that SHH/GLI signaling activity is indeed down-regulated in aggressive subtypes and advanced stages of BCC. The gene discussed is SHH; the disease is skin basal cell carcinoma.